ABEO Abeona Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABEO

Price (delayed)

$2.28

Market cap

$130.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$80.64M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 16
Highlights
The revenue has soared by 53% since the previous quarter
The company's gross profit rose by 48% QoQ
Abeona Therapeutics's net income has shrunk by 176% YoY
ABEO's EPS has dropped by 172% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.abeonatherapeutics.com
Peers: MRK

Key stats

What are the main financial stats of ABEO

ABEO stock price

How has the Abeona Therapeutics stock price performed over time
Intraday
-0.87%
1 week
-41.69%
1 month
-53.47%
1 year
-53.85%
YTD
-56.74%
QTD
-56.57%

Financial performance

How have Abeona Therapeutics's revenue and profit performed over time
Revenue
$39.01M
Gross profit
$25.38M
Operating income
-$70.81M
Net income
-$62.53M
Gross margin
65.1%
Net margin
-160.3%
Abeona Therapeutics's net income has shrunk by 176% YoY
Abeona Therapeutics's net margin has shrunk by 101% YoY but it has increased by 35% QoQ
ABEO's operating margin has soared by 99% YoY and by 43% QoQ
The revenue has soared by 53% since the previous quarter

Price vs fundamentals

How does ABEO's price correlate with its fundamentals

Growth

What is Abeona Therapeutics's growth rate over time

Valuation

What is Abeona Therapeutics stock price valuation
P/E
N/A
P/B
1.04
P/S
3.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.07
ABEO's EPS has dropped by 172% year-on-year
The price to book (P/B) is 68% lower than the 5-year quarterly average of 3.3 and 53% lower than the last 4 quarters average of 2.2
Abeona Therapeutics's equity has decreased by 26% YoY
ABEO's P/S is 97% below its 5-year quarterly average of 111.5 and 84% below its last 4 quarters average of 21.8
The revenue has soared by 53% since the previous quarter

Efficiency

How efficient is Abeona Therapeutics business performance
The company's return on assets has shrunk by 168% YoY and by 7% QoQ
The company's return on invested capital has shrunk by 158% YoY but it rose by 11% QoQ
Abeona Therapeutics's return on equity has shrunk by 157% YoY and by 7% QoQ
ABEO's ROS has dropped by 101% year-on-year but it is up by 48% since the previous quarter

Dividends

What is ABEO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABEO.

Financial health

How did Abeona Therapeutics financials performed over time
The current ratio has declined by 42% year-on-year and by 14% since the previous quarter
The company's quick ratio fell by 42% YoY and by 14% QoQ
Abeona Therapeutics's debt is 87% lower than its equity
Abeona Therapeutics's debt has decreased by 31% YoY and by 16% QoQ
Abeona Therapeutics's equity has decreased by 26% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.